BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Treatment
18 results:

  • 1. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and mecom mutations.
    Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
    Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lenalidomide Plus Hypomethylating Agent as a treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, mecom.
    Merz LE; Perissinotti AJ; Marini BL; Burke PW; Crouch A; Erba HP; Bixby D
    Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):24-30. PubMed ID: 31711889
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. evi1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase.
    Saito Y; Sawa D; Kinoshita M; Yamada A; Kamimura S; Suekane A; Ogoh H; Matsuo H; Adachi S; Taga T; Tomizawa D; Osato M; Soga T; Morishita K; Moritake H
    Haematologica; 2020 Aug; 105(8):2118-2129. PubMed ID: 31649131
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/lymphoma Study Group AML-05 study.
    Miyamura T; Moritake H; Nakayama H; Tanaka S; Tomizawa D; Shiba N; Saito AM; Tawa A; Shimada A; Iwamoto S; Hayashi Y; Koike T; Horibe K; Manabe A; Mizutani S; Taga T; Adachi S
    Br J Haematol; 2019 Apr; 185(2):284-288. PubMed ID: 30784060
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies.
    Suthandiram S; Gan GG; Zain SM; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
    Pharmacogenomics; 2014 Aug; 15(11):1479-94. PubMed ID: 25303299
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical characteristics of childhood leukemia with evi1 gene and BCR/ABL gene co-expression].
    Jiang M; Li XQ; Hu D; Zhang ZQ; Yang YY; Bai LC; Jin RM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 May; 16(5):489-93. PubMed ID: 24856998
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and review of the literature.
    Xu X; Su M; Levy NB; Mohtashamian A; Monaghan S; Kaur P; Zaremba C; Garcia R; Broome HE; Dell'Aquila ML; Wang HY
    Leuk Lymphoma; 2014 Nov; 55(11):2532-7. PubMed ID: 24397594
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and evi1.
    Smith KA; Cowell IG; Zhang Y; Sondka Z; Austin CA
    Genes Chromosomes Cancer; 2014 Feb; 53(2):117-28. PubMed ID: 24327541
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells.
    Xian XS; Park H; Choi MG; Park JM
    Anticancer Res; 2013 Jun; 33(6):2541-7. PubMed ID: 23749906
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells.
    Wasik AM; Almestrand S; Wang X; Hultenby K; Dackland ÅL; Andersson P; Kimby E; Christensson B; Sander B
    Cell Death Dis; 2011 Nov; 2(11):e225. PubMed ID: 22048168
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.
    Gustafsson K; Sander B; Bielawski J; Hannun YA; Flygare J
    Mol Cancer Res; 2009 Jul; 7(7):1086-98. PubMed ID: 19609004
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
    Gustafsson K; Christensson B; Sander B; Flygare J
    Mol Pharmacol; 2006 Nov; 70(5):1612-20. PubMed ID: 16936228
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.
    Flygare J; Gustafsson K; Kimby E; Christensson B; Sander B
    FEBS Lett; 2005 Dec; 579(30):6885-9. PubMed ID: 16337199
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
    Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
    Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Percutaneous treatment with amphotericin B of mycotic lung lesions from invasive aspergillosis: results in 10 immunocompromised patients.
    Veltri A; Anselmetti GC; Bartoli G; Martina MC; Regge D; Galli J; Bertini M
    Eur Radiol; 2000; 10(12):1939-44. PubMed ID: 11305575
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Detection of the Der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia.
    Kobayashi H; Satake N; Kaneko Y
    Leuk Lymphoma; 1997 Dec; 28(1-2):43-50. PubMed ID: 9498702
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Histamine and interleukin-2 in acute myelogenous leukemia.
    Hellstrand K; Mellqvist UH; Wallhult E; Carneskog J; Kimby E; Celsing F; Brune M
    Leuk Lymphoma; 1997 Nov; 27(5-6):429-38. PubMed ID: 9477124
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
    Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
    Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.